Insights of Neuro Oncology

ISSN: 2643-6094

Home / Insights of Neuro Oncology / Editorial Board / Dr. Sajeel A Chowdhary

Editorial board member | Dr. Sajeel A Chowdhary



Dr. Sajeel A Chowdhary

Director
Department of Medical Neuro-Oncology
Florida
United States of America
Tel: 56-955-6400

Dr. Sajeel A Chowdhary is a Director in the Department of Medical Neuro-Oncology at Marcus Neuroscience Institute, Florida, USA. Dr. Sajeel A Chowdhary completed his M.D, M.B.B.S in King Edward Medical College in Lahore, Pakistan. Dr. Sajeel A Chowdhary completed his Bachelor of Science (BSc) in 1993 at Punjab University in Lahore, Pakistan.Dr. Sajeel A Chowdhary completed his Fellow of Science at Punjab University in Lahore, Pakistan in 1990. Dr. Sajeel A Chowdhary is awarded for Resident Excellence Award in Clinical Neurology Cleveland Clinic Foundation (Florida Program) - Ft. Lauderdale, FL and Cleveland, OH in 2002. Dystonia Foundation Scholarship to Montreal Neurological Institute Montreal, Quebec, Canada in 2002. Boehringer-Ingelheim Fellowship Award for Parkinson’s DiseaseParkinson’s Foundation – Montreal, Quebec, Canada (Declined)in 2004. Dr. Sajeel A Chowdhary research interest includes in RTOG 9813 Phase III trial for newly diagnosed AA and AOA and randomized between Temozolamide and BCNU. (Coinvestigator. RTOG 0525 Phase III trial for newly diagnosed GBM tumors – randomization following XRT to conventional Temozolamide and dose intense Temozolamide. (Coinvestigator. RTOG Phase II trial for high risk low grade glioma to be treated with XRT and Temozolamide followed by adjuvant Temozolamide for upto 12 months (Coinvestigator. MCC 13663 - Gliasite Registry (Coinvestigator. NABTT AT-101 for newly diagnosed GBM tumors (MCC 14975). (Principle Investigator). Phase II study of utilizing irinotecan to treat recurrent malignant AA and AO (Coinvestigator). MCC 14814 TM-601 Phase II trial for recurrent AA, AO and GBM. (Coinvestigator). NABTT 0503 Phase I study utilizing EM-1421 for recurrent high grade gliomas. (Principle Investigator).